ASPG and autosomal dominant polycystic kidney disease: Such interventions could potentially disrupt the metabolic dependencies of cystic cells, offering a novel angle distinct from traditional signaling inhibitors; however, further research is necessary to elucidate the role of asparagine metabolism in ADPKD, and to assess the feasibility and safety of asparaginase-based therapies in this context.